FIP President Paul Sinclair AM MPS (left)[/caption]
‘Health care across the world is changing very quickly. It’s being driven by innovation, and pharmacists historically have embraced innovation and technology,' he said.
‘What excites me most about our profession at the moment is that we have the chance to do more. Our scope of practice is expanding rapidly, and with that comes opportunities to help more people deliver more outcomes and improve the health system.'
[post_title] => What are pharmacists doing in other countries?
[post_excerpt] => Pharmacists present to the International Pharmaceutical Federation (FIP) on unique services in their country to improve health and safety.
[post_status] => publish
[comment_status] => open
[ping_status] => open
[post_password] =>
[post_name] => what-are-pharmacists-doing-in-other-countries
[to_ping] =>
[pinged] =>
[post_modified] => 2024-09-04 16:43:37
[post_modified_gmt] => 2024-09-04 06:43:37
[post_content_filtered] =>
[post_parent] => 0
[guid] => https://www.australianpharmacist.com.au/?p=27474
[menu_order] => 0
[post_type] => post
[post_mime_type] =>
[comment_count] => 0
[filter] => raw
)
[title_attribute] => What are pharmacists doing in other countries?
[title] => What are pharmacists doing in other countries?
[href] => https://www.australianpharmacist.com.au/what-are-pharmacists-doing-in-other-countries/
[module_atts:td_module:private] => Array
(
)
[td_review:protected] => Array
(
)
[is_review:protected] =>
[post_thumb_id:protected] => 27493
[authorType] =>
)
Debbie Rigby FPS explaining how to correctly use different inhaler devices[/caption]
FIP award winner Dr Sarah Dineen-Griffin fourth from left[/caption]
Shania Liu received the Early Career in Pharmaceutical Practice Recognition Award. Presented every 3 years, the award recognises an educational program or innovation that promotes excellence in learning and teaching in any pharmacy discipline.
Dr Liu is the immediate past Chair of the Pain Management Leadership Committee of the Society of Hospital Pharmacists of Australia. Her research involved the improvement of the safe use of opioids before and after surgery.
Currently, she is a Postdoctoral Research Fellow in the Faculty of Medicine and Dentistry at the University of Alberta, Canada.
Sarah Dineen-Griffin was one of 10 new Fellows of FIP appointed at the Congress. FIP Fellowship recognises individual FIP members who have exhibited strong leadership internationally, distinguished themselves in pharmacy practice or the pharmaceutical sciences and who have contributed to the advancement of the practice of pharmacy or pharmaceutical sciences.
Dr Dineen-Griffin is a full-time teaching and research academic in the School of Biomedical Sciences and Pharmacy at the University of Newcastle. Currently she is Chief Investigator and Project Lead for the NSW/ACT Government Scope of Practice Pharmacy Trials. She is also the Vice President of the FIP Community Pharmacy Section.
[post_title] => FIP congress and two Australians honoured
[post_excerpt] => Find out what pharmacy topics are being discussed on the world stage at FIP, along with the Australians who received top honours.
[post_status] => publish
[comment_status] => open
[ping_status] => open
[post_password] =>
[post_name] => fip-congress-and-two-australians-honoured
[to_ping] =>
[pinged] =>
[post_modified] => 2024-09-03 11:02:11
[post_modified_gmt] => 2024-09-03 01:02:11
[post_content_filtered] =>
[post_parent] => 0
[guid] => https://www.australianpharmacist.com.au/?p=27411
[menu_order] => 0
[post_type] => post
[post_mime_type] =>
[comment_count] => 0
[filter] => raw
)
[title_attribute] => FIP congress and two Australians honoured
[title] => FIP congress and two Australians honoured
[href] => https://www.australianpharmacist.com.au/fip-congress-and-two-australians-honoured/
[module_atts:td_module:private] => Array
(
)
[td_review:protected] => Array
(
)
[is_review:protected] =>
[post_thumb_id:protected] => 27414
[authorType] =>
)
Queensland-based GP pharmacist Amy Gibson MPS[/caption]
Case scenarios
Dimitri, a 45-year-old male, presents to the pharmacy with a prescription for quinine 300 mg, one at night. He asks to speak with you, the pharmacist, and explains that he read online that quinine is used for malaria. He is concerned that he might have been prescribed the wrong medicine. You ask Dimitri what his medicine was prescribed for, and he explains that he needed a medicine to help with his leg cramps at night. He has no other health conditions.
Introduction
Off-label use of medicines is an accepted part of pharmacy practice. Off-label prescribing is defined as the prescribing of a medicine for an indication, dose, route or patient group outside that approved by the Therapeutic Goods Administration (TGA) for a specific listed product on it’s register of therapeutic goods.1 The term off-label use is often used interchangeably with off-label prescribing. Off-label use is not restricted to prescription medicines but may also extend to non-prescription medicines and medical devices. Off-label use of medicines is also a form of medicine repurposing.2
Learning Objectives |
THIS IS A CPD ARTICLE. YOU NEED TO BE A PSA MEMBER AND LOGGED IN TO READ MORE.
